<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344393/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344393</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>PRCC-TFE3 Forms Proline-dependent Condensates and Reprograms Chromatin for tRCC Oncogenic Transcription [RNA-seq]</name><description>Translocation renal cell carcinoma (tRCC) is an aggressive malignancy driven by MiT/TFE family transcription factor rearrangements, most notably TFE3 fusions. Among these, the PRCC::TFE3 fusion is a prominent oncogenic driver, yet the molecular mechanisms governing its transcriptional and tumorigenic activities remain poorly defined. Here, we demonstrate that PRCC::TFE3 forms dynamic, transcriptionally active nuclear condensates that are critical for its oncogenic function. We identify a proline-rich region within the PRCC fusion partner as the essential determinant of condensate formation. Disruption of this proline-rich region (PRW) abolishes condensate assembly, reverses fusion-driven chromatin accessibility and transcriptional reprogramming, and suppresses proliferative, migratory, and invasive phenotypes in patient-derived tRCC cell lines. Integrative RNA-seq, ATAC-seq, and CUT&amp;RUN analyses reveal that PRCC::TFE3 condensates function as epigenetic regulatory hubs, coordinating extensive chromatin remodeling and recruitment of transcription factor networks—including TEAD-associated pathways—to amplify oncogenic programs. Furthermore, we identify HS3ST2 and ABCB5 as novel, condensate-dependent target genes and validate them as critical mediators of tRCC progression. Our findings establish PRCC::TFE3-mediated condensate formation as a fundamental mechanism of tRCC pathogenesis and highlight condensate-dependent transcriptional networks as potential therapeutic vulnerabilities in this clinically challenging disease.</description><dates><publication>2026/08/20</publication></dates><accession>GSE344393</accession><cross_references><GSM>GSM9978344</GSM><GSM>GSM9978355</GSM><GSM>GSM9978343</GSM><GSM>GSM9978354</GSM><GSM>GSM9978346</GSM><GSM>GSM9978357</GSM><GSM>GSM9978356</GSM><GSM>GSM9978345</GSM><GSM>GSM9978348</GSM><GSM>GSM9978347</GSM><GSM>GSM9978349</GSM><GSM>GSM9978351</GSM><GSM>GSM9978350</GSM><GSM>GSM9978353</GSM><GSM>GSM9978352</GSM><GPL>34284</GPL><GSE>344393</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>